Ignite Creation Date:
2025-12-24 @ 4:35 PM
Ignite Modification Date:
2025-12-24 @ 4:35 PM
Study NCT ID:
NCT04358666
Status:
UNKNOWN
Last Update Posted:
2020-04-24
First Post:
2020-03-31
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Evaluation of the Best Treatment in Terms of Quality of Life for Patients Having a Brain Metastasis
Sponsor:
University Hospital, Caen
Organization:
Study Overview
Official Title:
Evaluation of the Best Treatment in Terms of Quality of Life for Patients Having a Brain Metastasis
Status:
UNKNOWN
Status Verified Date:
2020-03
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
OPTMETACER
Brief Summary:
Main Goal : evaluation of quality of life for patient having a brain metastasis and allowed to have either surgery and radiosurgery of the surgical site or only hypofractionned radiosurgery on the lesion.
second objectives : evaluation of the local control of the disease evaluation of the overall survival interval without progression evaluation of the medico economic performance of each treatment protocol neuro cognitive evaluation at the end of the protocol
second objectives : evaluation of the local control of the disease evaluation of the overall survival interval without progression evaluation of the medico economic performance of each treatment protocol neuro cognitive evaluation at the end of the protocol
Detailed Description:
A patient with a brain metastasis may have the choice between surgery and focal radiosurgery of the surgical site and only hypofractionned radiosurgery on the lesion.
No previous study has focused on quality of life regarding these two treatments options.
No previous study has focused on quality of life regarding these two treatments options.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: